Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...
The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a ...
When women taking weight loss jabs stop their use because of pregnancy, the rebound weight gain brings health risks for their ...
FAT jabs could harm mum and baby if taken too close to pregnancy, a study suggests. Women who used the GLP-1 injections, such ...
Novo Nordisk cuts self-pay prices for Wegovy and Ozempic in the United States, aiming to expand access and counter falling ...
The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.
Vascular dementia is the second-most common form of dementia after Alzheimer's. About 2.7 million people in the U.S. are thought to have mixed dementia or vascular dementia, which is caused by strokes ...
Four in five people put the weight back on after coming of weight loss jabs, new research has suggested today-and they're not ...
Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the ...
An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...
The oral version of Rybelsus failed to meet its primary goal in two late-stage clinical trials, which aimed to evaluate its ...
Tim Seymour, Seymour Asset Management CIO, said in a recent program on CNBC that markets remain worried about AI valuations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback